{"id":1567,"date":"2025-12-20T23:32:49","date_gmt":"2025-12-20T23:32:49","guid":{"rendered":"https:\/\/lily.show\/?p=1567"},"modified":"2026-02-10T00:16:58","modified_gmt":"2026-02-10T00:16:58","slug":"elementor-1567","status":"publish","type":"post","link":"https:\/\/lily.show\/?p=1567","title":{"rendered":"NOOPEPT – Deep Dive"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

BRAIN OPTIMIZATION QUEST ARTICLE 1<\/b><\/p>

A deep dive on Noopept<\/b><\/p>

Noopept is Russian pharmacology at its finest. It is bioavailable orally, being N-phenylacetyl-L-prolyl-glycine ethyl ester, the phenylacetyl and ethyl ester protect it from peptidases. It was developed as an alternative to racetams, and is what I consider to be a legitimate nootropic, as compared to adderall which is a neurotoxic slum of excitotoxicity (this is a harsh overexaggeration\u2013 it’s dose dependent).\u00a0<\/span><\/p>

I do believe the societal perception of nootropics is skewed. We expect to instantaneously be able to feel them, craving the catecholamine cascade. Noopept works on a more fundamental, deep and architectural level. Its main application is learning and sports performance (It is not explicitly on the WADA prohibited list). Just to be clear, noopept is <\/span>NOT <\/b>a racetam.\u00a0<\/span><\/p>

If you are new here, In addition to hard, consistent learning and training bouts I am attempting to stack all of the possible variables to become as high performing as I possibly can. A day natty is a day wasted\u2013 we have tools. So lets learn how to use them!\u00a0<\/span><\/p>

For this article I included Layman’s explanations. I plan to do them for the ones ahead\u2013 I fear I can get carried away sometimes.\u00a0<\/span><\/p>

Metabolite-Driven Effects<\/b><\/p>

Noopept itself has quite a short halflife, but in animal studies its metabolite cycloprolyglycine is found to linger, thus thought to be responsible for its nootropic effects. Cycloprolyglycine (CPG) is a metabolite of IGF-1 (<\/span>Gudasheva.) Noopept almost acts as a CPG prodrug, and GPG endogenously modulates neuroprotection and synaptic plasticity (Guan.)\u00a0<\/span><\/p>

CPG competes for binding with IGFBP-3 in the bloodstream (which typically holds a large amount of IGF-1) potentially increasing IGF bioavailability as a whole. This does not imply more anabolism, just moves the needle positively to more bioavailability\u2013 which has a greater sway on the brain than the muscles.\u00a0<\/span><\/p>

Noopept has two other metabolites in addition to CPG, being phenylacetic acid and prolylglycine. Phenylacetic acid doesn\u2019t have any nootropic effects, and is inert. Prolylglycine is a precursor to Cycloprolyglycine. Cycloprolyglycine is the heavy hitter, the concentration of which was found 2.5 fold higher after 1 hour whereas everything else was undetectable in rodent studies (Gudasheva)\u00a0<\/span><\/p>

LAYMANS EXPLINATION:<\/b><\/p>

Noopept itself quickly turns into another compound called cycloprolylglycine, which exerts the effects. Cycloprolylglycine is something the body already makes, and it plays a role in protecting brain cells and supporting learning. It is a metabolite of IGF-1. Since its effects are based on something that is natural to our body, it makes its effects slightly more predictable and understandable even with a smaller amount of data.\u00a0<\/span><\/p>

Noopepts Mechanism of Action<\/b><\/p>

(If you do not want a complicated explanation, check the next section for a layman’s synopsis.) The generally overarching MOA is that Noopept enhances activity-dependent plasticity signaling, most likely by facilitating or amplifying signaling toward CREB phosphorylation, which in turn yields neurotrophin expression such as BDNF. CREB is a step in the cascade that, when activated, initiates transcription of plasticity-related genes (see visual). This cascade is biased toward ACTIVE circuits. For example, it will not make you better at baseball if you have not picked up a bat in five years, but it could potentially enhance learning within circuits that are being actively engaged.<\/span><\/p>

Cycloprolylglycine\u2019s positive modulation of NMDA-dependent signaling is relevant here, as it appears to make NMDA signaling more effective for plasticity rather than simply stronger. This does not mean there is an overall increase in excitation. The effects appear to rely on intact AMPA signaling while biasing NMDA pathways toward plasticity.\u00a0<\/span><\/p>

NMDA-mediated calcium signaling is one of the primary pathways leading to CREB activation during learning, which in turn drives the transcription of plasticity-related genes. I do not intend on being overly reductive.\u00a0<\/span><\/p>

Preclinical work also suggests a neuroprotective aspect of Noopept, particularly under conditions of metabolic or excitotoxic stress\u2013 such as increased neuron survival with excess glutamate. This increase, at least in rodent models, seems to be localized to the hippocampus.<\/span><\/p>

\u00a0<\/span><\/p>

LAYMANS EXPLANATION:\u00a0<\/b><\/p>

Noopept does not impact unused circuits\/skills. It seems to support and strengthen learning in areas of the brain that are active, especially those involved in memory. It does this by making areas of the brain more receptive to signals that are key for memory formation.<\/span><\/p>

SUMMARY OF AVAILABLE EVIDENCE<\/b><\/p>

ANIMAL STUDIES:\u00a0<\/b><\/p>